Cor Vasa 2009, 51(Suppl.):48-51 | DOI: 10.33678/cor.2009.222

Acute coronary syndromes without persistent ST elevation in the light of the 2007 and 2008 guidelines

David Horák
Kardiocentrum, Krajská nemocnice Liberec a. s., Liberec, Česká republika

New guidelines for the management of acute coronary syndromes without persistent ST elevation were published in 2007 and 2008. The paper addresses new and several somewhat neglected aspects of these guidelines. The new guidelines highlight the need for preventing bleeding complications and for a balanced management in terms of benefits of ischemia/bleeding. Methods of risk stratification are employed to optimize therapy, and mention is also made of the occasionally neglected risk scores.

Keywords: NSTEMI; Bleeding; Ischemia; Risk stratification

Published: December 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Horák D. Acute coronary syndromes without persistent ST elevation in the light of the 2007 and 2008 guidelines. Cor Vasa. 2009;51(Suppl.):48-51. doi: 10.33678/cor.2009.222.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bassand JP. Task Force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology. Eur Heart J 2008;28:1-63.
    2. Bělohlávek J, Aschermann M. Doporučený postup pro diagnostiku a léčbu akutních koronárních syndromů bez elevací ST úseků na EKG. Cor Vasa 2008;50: 1S7-1S23.
    3. Moscucci M. Predictors of Major Bleeding in ACS: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003;24:1815-23. Go to original source... Go to PubMed...
    4. Rao SV. Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. Am J Cardiol 2005;96:1200-6. Go to original source... Go to PubMed...
    5. Eikelboom JW. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 2006;114:774-82. Go to original source... Go to PubMed...
    6. Pannu N. Prophylaxis strategies for contrast-induced nephropathy. JAMA 2006;295:2765-79. Go to original source... Go to PubMed...
    7. Manoukian SV. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY trial. J Am Coll Cardiol 2007;49:1362-8. Go to original source... Go to PubMed...
    8. Hamon M. Prognostic impact of major bleeding in patients with acute coronary syndromes. EuroInterv 2007;3:400-8. Go to original source... Go to PubMed...
    9. Rao SV. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004;292:1555-62. Go to original source... Go to PubMed...
    10. Al-Khatib SM. Sustained ventricular arrhytmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes. Circulation 2002;106:309-12. Go to original source...
    11. Mehta SR. Routine vs. selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA 2005;293:2908-17. Go to original source... Go to PubMed...
    12. Yusuf S. Efficacy and safety of fondaparinux compared to enoxaparin in 20,078 patient with acute coronary syndromes without ST segment elevation. The OASIS (Organization to Assess Strategies in Acute Ischemic Syndromes)-5 Investigators. N Engl J Med 2006;354:1464-76. Go to original source...
    13. Roffi M. Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment elevation acute coronary syndromes. Circulation 2001;104:2767-71. Go to original source... Go to PubMed...
    14. Kastrati A. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial. JAMA 2006;295:1531-8. Go to original source... Go to PubMed...
    15. Jolly S. Radial versus femoral access for coronary angioraphy or intervention and the impact on major bleeding and ischemic events: A systematic review and meta-analysis of randomized trials. Am Heart J 2009;157: 132-40. Go to original source... Go to PubMed...
    16. Agostoni P. Radial versus femoral approach in percutaneous transluminal coronary angioplasty and interventional procedures: systematic overview and metaanalysis of randomized trials. J Am Coll Cardiol 2004;44: 349-56. Go to original source... Go to PubMed...
    17. Chase AJ. Association of the arterial access with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Trasfusion after percutaneous coronary intervention via Arm or Leg). Heart 2008;94:1019-35.

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes